Evidence map›Paper›PMID 42602727›Full record

ArticleCase reports in obstetrics and gynecology2026

Case Report of an Aggressive Angiomyxoma Presenting as Pelvic Organ Prolapse.

Joris Ramstein, Charlotte Ter Haar, Noelani Guaderrama, Audai Alrwashdeh, Jennifer Lee

Abstract read
In one paragraph

Article in Case reports in obstetrics and gynecology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Joris RamsteinDepartment of OBGYN, University of California, Irvine Medical Center, Orange, California, USA, berkeley.edu.ORCID https://orcid.org/0000-0002-0357-7273
Charlotte Ter HaarDepartment of OBGYN, University of California, Irvine Medical Center, Orange, California, USA, berkeley.edu.ORCID https://orcid.org/0000-0002-4048-4455
Noelani GuaderramaDepartment of OBGYN, Southern California Permanente Medical Group, Orange, California, USA, kaiserpermanente.org.ORCID https://orcid.org/0000-0002-8756-6888
Audai AlrwashdehDepartment of Pathology, Southern California Permanente Medical Group, Orange, California, USA, kaiserpermanente.org.ORCID https://orcid.org/0009-0006-8031-4991
Jennifer LeeDepartment of OBGYN, Southern California Permanente Medical Group, Orange, California, USA, kaiserpermanente.org.ORCID https://orcid.org/0000-0003-4961-0195

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aggressive angiomyxoma (AAM) is a rare, slow-growing, locally infiltrative mesenchymal tumor of the pelvis and perineum, most often affecting women. Its nonspecific presentation and tendency to mimic more common vaginal or periurethral masses frequently delay diagnosis. Early recognition is critical to guide appropriate surgical planning, optimize resection, and reduce recurrence risk. In this case, a 61-year-old woman with prior vaginal hysterectomy presented with symptoms of pelvic organ prolapse, urinary incontinence, and occasional bleeding. Examination revealed a 10 × 3-cm protruding anterior vaginal wall mass with a spongy texture. MRI demonstrated a well-defined tubular lesion in the left distal vaginal wall extending towards the vulva. Intraoperative evaluation, including cystourethroscopy, diagnostic laparoscopy, and general surgery consultation, ruled out bowel involvement. The mass was excised via vaginal approach with preservation of surrounding structures. Histopathology confirmed AAM. Margins could not be assessed due to specimen disruption. At 6-week follow-up, the patient was asymptomatic with well-healed incisions, and ongoing surveillance with gynecologic oncology was arranged. This case highlights the importance of including AAM in the differential diagnosis of anterior vaginal wall masses. Multidisciplinary collaboration and advanced imaging are essential for accurate diagnosis and surgical planning. Given the tumor's locally infiltrative nature and high recurrence rate, long-term follow-up is warranted. Awareness of this rare pathology can aid timely recognition and improve patient outcomes.

Indexed as

angiomyxomacase reportvaginal mass

Identifiers

PMID42602727
PMCPMC13475007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.